<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02535481</url>
  </required_header>
  <id_info>
    <org_study_id>15/0079</org_study_id>
    <nct_id>NCT02535481</nct_id>
  </id_info>
  <brief_title>Epidermal Grafting in Wound Healing</brief_title>
  <acronym>EPIGRAAFT</acronym>
  <official_title>A Multi-centre Randomised Controlled Trial to Compare Epidermal Grafting With Split Skin Grafting for Wound Healing</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University College, London</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University College, London</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Split thickness skin grafting is the normal standard of care for wound closure. However, this&#xD;
      is an invasive procedure and associated with pain also there can be additional donor site&#xD;
      morbidity. Epidermal grafting is an emerging clinical alternative that is gaining clinical&#xD;
      practise. Epidermal grafting (EG) is an alternative method of autologous skin grafting that&#xD;
      'harvests' a finer layer of skin than traditional Split thickness skin grafting (SSG). This&#xD;
      potentially results in less pain and reduced donor site morbidity but only delivers several&#xD;
      cell layers to the wound so may be less effective at healing a wound. It is not known if EG&#xD;
      is an effective alternative to SSG.&#xD;
&#xD;
      Further the mechanism to achieve wound healing may be different. EG promotes wound healing by&#xD;
      expressing growth factors that accelerates wound healing and encourages keratinocyte&#xD;
      migration. Whereas SSG is a transplant of several skin layers that integrated to the existing&#xD;
      wound bed as a formal skin covering.&#xD;
&#xD;
      The investigators wish to compare these two clinical practises; epidermal grafting and split&#xD;
      thickness skin grafting in wound healing. Further to undertake a translational study to&#xD;
      investigate the mechanism by which each technique achieves wound healing.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study evaluates the efficacy of EG, as an alternative to current wound management&#xD;
      therapy, SSG. In a pilot study carried out in our centre (unpublished data), the&#xD;
      investigators noted that this technique offers a method of autologous skin harvesting with&#xD;
      minimal or no pain and a scar free donor site. Moreover, complete wound epithelialisation was&#xD;
      achieved while maintaining patient independence. Therefore, this device has the potential to&#xD;
      save healthcare resources, by eliminating the need for theatre space and a hospital bed, and&#xD;
      result in better Patient Reported Outcomes Measures.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 2015</start_date>
  <completion_date type="Actual">November 2017</completion_date>
  <primary_completion_date type="Actual">August 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Wounds With Complete Healing</measure>
    <time_frame>6 weeks and 3 months</time_frame>
    <description>Number of wounds with complete healing at 6 weeks</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Mean Time for Donor Site Healing</measure>
    <time_frame>3 months</time_frame>
    <description>Complete donor site healing was defined as 100% re-epithelialisation and not requiring further dressings</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time for Wound Healing</measure>
    <time_frame>3 months</time_frame>
    <description>Complete wound healing was defined as 100% re-epithelialisation and not requiring further dressings</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Donor Site Morbidity</measure>
    <time_frame>6 weeks and 3 months</time_frame>
    <description>The donor site morbidity was measured using the Vancouver Scar Scale (VSS). Total score scale ranges from 0 to 13. Lower score is more desirable as it represents a scar resembling normal surrounding skin. The scale assesses 4 categories: vascularity, height, pliability, and pigmentation. Total score is obtained by the sum of the categories.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Reported Outcome Measure (PROM)</measure>
    <time_frame>6 weeks and 3 months</time_frame>
    <description>Patient reported outcome measure was assessed using a validated skin graft satisfaction questionnaire.The skin graft satisfaction questionnaire has a scale ranging from 1 to 7, with 1 representing very unsatisfied while 7 represents very satisfied. Hence, higher score represent higher satisfaction.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse Events</measure>
    <time_frame>3 months</time_frame>
    <description>Number of participants with of adverse events</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">44</enrollment>
  <condition>Ulcer</condition>
  <condition>Skin Ulcer</condition>
  <condition>Wounds and Injuries</condition>
  <arm_group>
    <arm_group_label>Epidermal Graft</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The Cellutome Epidermal Graft Harvesting System will be used to harvest epidermal grafts as per existing normal clinical practice.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Split Thickness Skin Graft</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Split thickness skin graft will be harvested using air dermatome as per normal clinical practise.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Epidermal grafting</intervention_name>
    <description>The Cellutome Epidermal Graft Harvesting System will be used to harvest epidermal grafts.</description>
    <arm_group_label>Epidermal Graft</arm_group_label>
    <other_name>CelluTome</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Split thickness skin grafting</intervention_name>
    <description>Split thickness skin grafting will be performed as per normal clinical practice.</description>
    <arm_group_label>Split Thickness Skin Graft</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Male or female&#xD;
&#xD;
          2. Age 18-90&#xD;
&#xD;
          3. Wound measuring more than 1cm x 1cm and lesser than 5cm x 5cm (1% TBSA)&#xD;
&#xD;
          4. Wound with clean, healthy granulating bed, with minimal adherent slough&#xD;
&#xD;
          5. Patient understands and is willing to participate and can comply with weekly visits&#xD;
             and follow-up regime&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Wound with active infection&#xD;
&#xD;
          2. Wound at plantar of the foot&#xD;
&#xD;
          3. Patients unsuitable for Split Skin Grafting&#xD;
&#xD;
          4. Previous history of excessive bleeding associated with surgical biopsies or trauma&#xD;
&#xD;
          5. Allergies to tegaderm (and other dressings used in the study)&#xD;
&#xD;
          6. Known uncontrolled Diabetes Mellitus, as measured by an HbA1c &gt; 10%.&#xD;
&#xD;
          7. Presence of one or more medical conditions, including renal, hepatic, hematologic,&#xD;
             active auto-immune or immune diseases that, would make the subject an inappropriate&#xD;
             candidate for this ulcer healing study&#xD;
&#xD;
          8. Patient not fit for surgery (ASA classification &gt; 4)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Toby Richards, MD FRCS</last_name>
    <role>Principal Investigator</role>
    <affiliation>University College, London</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Afshin Mosahebi, MBBS FRCS PhD MBA</last_name>
    <role>Principal Investigator</role>
    <affiliation>Royal Free Hospital NHS Foundation Trust</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Royal Free Hampstead NHS Trust Hospital</name>
      <address>
        <city>London</city>
        <zip>NW3 2QG</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>August 11, 2015</study_first_submitted>
  <study_first_submitted_qc>August 25, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 28, 2015</study_first_posted>
  <results_first_submitted>June 2, 2020</results_first_submitted>
  <results_first_submitted_qc>July 24, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">August 10, 2020</results_first_posted>
  <last_update_submitted>July 24, 2020</last_update_submitted>
  <last_update_submitted_qc>July 24, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">August 10, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>epidermal graft</keyword>
  <keyword>suction blister</keyword>
  <keyword>blister graft</keyword>
  <keyword>suction graft</keyword>
  <keyword>Epidermis/su, tr [Surgery, Transplantation]</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Skin Ulcer</mesh_term>
    <mesh_term>Ulcer</mesh_term>
    <mesh_term>Wounds and Injuries</mesh_term>
  </condition_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>October 18, 2016</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/81/NCT02535481/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <recruitment_details>A total of 61 patients were screened for eligibility; 44 of them fulfilled the inclusion criteria and were randomized to the two study groups (EG and SSG) between October 2015 and September 2017. Participants were recruited at the Royal Free London NHS Foundation Trust Hospital.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Epidermal Graft</title>
          <description>Epidermal grafting: The Cellutome Epidermal Graft Harvesting System was used to harvest epidermal grafts.</description>
        </group>
        <group group_id="P2">
          <title>Split Thickness Skin Graft</title>
          <description>Split thickness skin grafting: Split thickness skin grafting was performed as per normal clinical practice.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="22"/>
                <participants group_id="P2" count="22"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="22"/>
                <participants group_id="P2" count="22"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Epidermal Graft</title>
          <description>Epidermal grafting: The Cellutome Epidermal Graft Harvesting System was used to harvest epidermal grafts.</description>
        </group>
        <group group_id="B2">
          <title>Split Thickness Skin Graft</title>
          <description>Split thickness skin grafting: Split thickness skin grafting was performed as per normal clinical practice.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="22"/>
            <count group_id="B2" value="22"/>
            <count group_id="B3" value="44"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="22"/>
                    <count group_id="B2" value="22"/>
                    <count group_id="B3" value="44"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="58.1" spread="19.9"/>
                    <measurement group_id="B2" value="59" spread="18"/>
                    <measurement group_id="B3" value="58.7" spread="19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="22"/>
                    <count group_id="B2" value="22"/>
                    <count group_id="B3" value="44"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="14"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                    <measurement group_id="B2" value="17"/>
                    <measurement group_id="B3" value="30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Wound size (cm^2)</title>
          <units>cm^2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="22"/>
                    <count group_id="B2" value="22"/>
                    <count group_id="B3" value="44"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="12.7" spread="9.9"/>
                    <measurement group_id="B2" value="16.5" spread="11"/>
                    <measurement group_id="B3" value="14.6" spread="10.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Duration of wound (week)</title>
          <units>week</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="22"/>
                    <count group_id="B2" value="22"/>
                    <count group_id="B3" value="44"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="48.9" spread="75.4"/>
                    <measurement group_id="B2" value="7.86" spread="16.1"/>
                    <measurement group_id="B3" value="28.4" spread="58.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Wounds With Complete Healing</title>
        <description>Number of wounds with complete healing at 6 weeks</description>
        <time_frame>6 weeks and 3 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Epidermal Graft</title>
            <description>Epidermal grafting: The Cellutome Epidermal Graft Harvesting System was used to harvest epidermal grafts.</description>
          </group>
          <group group_id="O2">
            <title>Split Thickness Skin Graft</title>
            <description>Split thickness skin grafting: Split thickness skin grafting was performed as per normal clinical practice.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Wounds With Complete Healing</title>
          <description>Number of wounds with complete healing at 6 weeks</description>
          <units>number of wounds</units>
          <param>Number</param>
          <units_analyzed>Number of wounds</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="22"/>
                <count group_id="O2" value="22"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>Number of wounds</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="22"/>
                <count group_id="O2" value="22"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>6 weeks</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9"/>
                    <measurement group_id="O2" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16"/>
                    <measurement group_id="O2" value="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.366</p_value>
            <p_value_desc>At 6 weeks</p_value_desc>
            <method>Fisher Exact</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.24</p_value>
            <p_value_desc>At 3 months</p_value_desc>
            <method>Fisher Exact</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Mean Time for Donor Site Healing</title>
        <description>Complete donor site healing was defined as 100% re-epithelialisation and not requiring further dressings</description>
        <time_frame>3 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Epidermal Graft</title>
            <description>Epidermal grafting: The Cellutome Epidermal Graft Harvesting System was used to harvest epidermal grafts.</description>
          </group>
          <group group_id="O2">
            <title>Split Thickness Skin Graft</title>
            <description>Split thickness skin grafting: Split thickness skin grafting was performed as per normal clinical practice.</description>
          </group>
        </group_list>
        <measure>
          <title>Mean Time for Donor Site Healing</title>
          <description>Complete donor site healing was defined as 100% re-epithelialisation and not requiring further dressings</description>
          <units>days</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="22"/>
                <count group_id="O2" value="22"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.86" lower_limit="4.41" upper_limit="5.32"/>
                    <measurement group_id="O2" value="21.32" lower_limit="15.65" upper_limit="26.99"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>&lt;0.0001</p_value>
            <method>Log Rank</method>
            <method_desc>Kaplan-Meier analysis of cumulative wound healing followed by a log rank test</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Time for Wound Healing</title>
        <description>Complete wound healing was defined as 100% re-epithelialisation and not requiring further dressings</description>
        <time_frame>3 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Epidermal Graft</title>
            <description>Epidermal grafting: The Cellutome Epidermal Graft Harvesting System was used to harvest epidermal grafts.</description>
          </group>
          <group group_id="O2">
            <title>Split Thickness Skin Graft</title>
            <description>Split thickness skin grafting: Split thickness skin grafting was performed as per normal clinical practice.</description>
          </group>
        </group_list>
        <measure>
          <title>Time for Wound Healing</title>
          <description>Complete wound healing was defined as 100% re-epithelialisation and not requiring further dressings</description>
          <units>week</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="22"/>
                <count group_id="O2" value="22"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.81" lower_limit="6.44" upper_limit="9.19"/>
                    <measurement group_id="O2" value="6.59" lower_limit="5.29" upper_limit="7.89"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.12</p_value>
            <method>Log Rank</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Donor Site Morbidity</title>
        <description>The donor site morbidity was measured using the Vancouver Scar Scale (VSS). Total score scale ranges from 0 to 13. Lower score is more desirable as it represents a scar resembling normal surrounding skin. The scale assesses 4 categories: vascularity, height, pliability, and pigmentation. Total score is obtained by the sum of the categories.</description>
        <time_frame>6 weeks and 3 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Epidermal Graft</title>
            <description>Epidermal grafting: The Cellutome Epidermal Graft Harvesting System was used to harvest epidermal grafts.</description>
          </group>
          <group group_id="O2">
            <title>Split Thickness Skin Graft</title>
            <description>Split thickness skin grafting: Split thickness skin grafting was performed as per normal clinical practice.</description>
          </group>
        </group_list>
        <measure>
          <title>Donor Site Morbidity</title>
          <description>The donor site morbidity was measured using the Vancouver Scar Scale (VSS). Total score scale ranges from 0 to 13. Lower score is more desirable as it represents a scar resembling normal surrounding skin. The scale assesses 4 categories: vascularity, height, pliability, and pigmentation. Total score is obtained by the sum of the categories.</description>
          <units>unit of a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="22"/>
                <count group_id="O2" value="22"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>6 weeks</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.14" spread="0.45"/>
                    <measurement group_id="O2" value="3.73" spread="0.69"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.09" spread="0.29"/>
                    <measurement group_id="O2" value="2.91" spread="0.67"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.001</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Patient Reported Outcome Measure (PROM)</title>
        <description>Patient reported outcome measure was assessed using a validated skin graft satisfaction questionnaire.The skin graft satisfaction questionnaire has a scale ranging from 1 to 7, with 1 representing very unsatisfied while 7 represents very satisfied. Hence, higher score represent higher satisfaction.</description>
        <time_frame>6 weeks and 3 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Epidermal Graft</title>
            <description>Epidermal grafting: The Cellutome Epidermal Graft Harvesting System was used to harvest epidermal grafts.</description>
          </group>
          <group group_id="O2">
            <title>Split Thickness Skin Graft</title>
            <description>Split thickness skin grafting: Split thickness skin grafting was performed as per normal clinical practice.</description>
          </group>
        </group_list>
        <measure>
          <title>Patient Reported Outcome Measure (PROM)</title>
          <description>Patient reported outcome measure was assessed using a validated skin graft satisfaction questionnaire.The skin graft satisfaction questionnaire has a scale ranging from 1 to 7, with 1 representing very unsatisfied while 7 represents very satisfied. Hence, higher score represent higher satisfaction.</description>
          <units>score on a scale</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="22"/>
                <count group_id="O2" value="22"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>6 weeks</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7" lower_limit="7" upper_limit="7"/>
                    <measurement group_id="O2" value="6" lower_limit="5" upper_limit="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7" lower_limit="7" upper_limit="7"/>
                    <measurement group_id="O2" value="6" lower_limit="6" upper_limit="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.001</p_value>
            <p_value_desc>At 6 weeks</p_value_desc>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.001</p_value>
            <p_value_desc>At 3 months</p_value_desc>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Adverse Events</title>
        <description>Number of participants with of adverse events</description>
        <time_frame>3 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Epidermal Graft</title>
            <description>Epidermal grafting: The Cellutome Epidermal Graft Harvesting System was used to harvest epidermal grafts.</description>
          </group>
          <group group_id="O2">
            <title>Split Thickness Skin Graft</title>
            <description>Split thickness skin grafting: Split thickness skin grafting was performed as per normal clinical practice.</description>
          </group>
        </group_list>
        <measure>
          <title>Adverse Events</title>
          <description>Number of participants with of adverse events</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="22"/>
                <count group_id="O2" value="22"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>3 months</time_frame>
      <desc>The incidence of serious adverse events (SAEs) include mortality of any cause within the three months duration from the time of initial therapy, and the incidence of device-related adverse events (DAEs) and wound-related adverse events (WAEs) occurring within the study duration.</desc>
      <group_list>
        <group group_id="E1">
          <title>Epidermal Graft</title>
          <description>Epidermal grafting: The Cellutome Epidermal Graft Harvesting System was used to harvest epidermal grafts.</description>
        </group>
        <group group_id="E2">
          <title>Split Thickness Skin Graft</title>
          <description>Split thickness skin grafting: Split thickness skin grafting was performed as per normal clinical practice.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>EPIGRAAFT Trial team</name_or_title>
      <organization>UCL</organization>
      <phone>020 7679 2000</phone>
      <email>epigraaft@gmail.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

